EUVIMEDEUVIMED entdecken
Open Access

Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation

Moriyasu Anai, Koichi Saruwatari, Kosuke Imamura, Kosuke Fujino, Takayuki Jodai, Shinya Sakata, Shinji Iyama, Yusuke Tomita, Sho Saeki, Hidenori Ichiyasu, Koei Ikeda, Makoto Suzuki und 1 weitere

Journal of Thoracic Disease · 2024-02 · 16 (2) · 1151-1160

DOI: 10.21037/jtd-23-1723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2024-02. Verfasst von Moriyasu Anai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical impact of tumor microvessels on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in EGFR mutation-positive non-small cell lung cancer (NSCLC) is unclear. Thus, the aim of this study was to investigate whether a tumor microenvironment, abundant in microvessels, affects EGFR-TKI efficacy in patients with NSCLC and EGFR mutations.

Methods

We retrospectively studied the data of 40 post-operative patients with recurrent NSCLC and EGFR mutations who received EGFR-TKIs as a first-line treatment at Kumamoto University Hospital from January 2010 to February 2021. Tumor sections were retrieved from the tissue registry and analyzed for CD34-positive microvessels using immunohistochemical techniques. The ratio of microvascular area to tumor area (RMV), which is the CD34-positive microvascular area compared to the total tumor area, was measured using StrataQuest. The predictive value of RMV on treatment outcome, assessed via progression-free survival (PFS), was evaluated using a multivariate Cox proportional hazard model.

Results

The median PFS in the high RMV group (≥0.058) was significantly shorter than that in the low RMV group [

Schlagwörter

Stichwörter der Autor:innen

Non-small cell lung cancer (NSCLC)epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)microvascular areamicrovascular density (MVD)

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Thoracic Surgery, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Zitieren

APA

Anai, M., Saruwatari, K., Imamura, K., Fujino, K., Jodai, T., Sakata, S., Iyama, S., Tomita, Y., Saeki, S., Ichiyasu, H., Ikeda, K., Suzuki, M., & Sakagami, T. (2024). Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation. Journal of Thoracic Disease, 16(2), 1151-1160. https://doi.org/10.21037/jtd-23-1723

Vancouver

Anai M, Saruwatari K, Imamura K, Fujino K, Jodai T, Sakata S, et al. Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation. Journal of Thoracic Disease. 2024;16(2):1151-1160. doi:10.21037/jtd-23-1723

BibTeX
@article{Anai2024,
  author = {Anai, Moriyasu and Saruwatari, Koichi and Imamura, Kosuke and Fujino, Kosuke and Jodai, Takayuki and Sakata, Shinya and Iyama, Shinji and Tomita, Yusuke and Saeki, Sho and Ichiyasu, Hidenori and Ikeda, Koei and Suzuki, Makoto and Sakagami, Takuro},
  title = {Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation},
  journal = {Journal of Thoracic Disease},
  year = {2024},
  volume = {16},
  number = {2},
  pages = {1151--1160},
  doi = {10.21037/jtd-23-1723}
}
Kostenlos starten →